{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T01:07:40Z","timestamp":1765328860497,"version":"3.46.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:00:00Z","timestamp":1760227200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology Plus"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jmccpl.2025.100489","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T10:21:40Z","timestamp":1760696500000},"page":"100489","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cardiac magnetic resonance imaging and cardiac scintigraphy in the diagnosis of cardiac amyloidosis: A meta-analysis of 4866 patients"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4744-1703","authenticated-orcid":false,"given":"Mahmoud","family":"Balata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdelrahman","family":"M.Attia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed Ibrahim","family":"Gbreel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mamdouh","family":"Elsmaan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marwa","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Rapeanu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milka","family":"Marinova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc Ulrich","family":"Becher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Islam","family":"Ebeid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasmin","family":"Ortak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00fcseyin","family":"Ince","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.jmccpl.2025.100489_bb0005","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1056\/NEJM199709253371306","article-title":"The systemic amyloidoses","volume":"337","author":"Falk","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmccpl.2025.100489_bb0010","first-page":"107","article-title":"The systemic amyloidoses: an overview","volume":"45","author":"Falk","year":"2000","journal-title":"Adv Intern Med"},{"issue":"2","key":"10.1016\/j.jmccpl.2025.100489_bb0015","doi-asserted-by":"crossref","first-page":"36","DOI":"10.14797\/mdcvj.1061","article-title":"Clinical clues and diagnostic workup of cardiac amyloidosis","volume":"18","author":"Gill","year":"2022","journal-title":"Methodist Debakey Cardiovasc J"},{"issue":"6","key":"10.1016\/j.jmccpl.2025.100489_bb0020","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12062273","article-title":"Estimating the prevalence of cardiac amyloidosis in old patients with heart failure-barriers and opportunities for improvement: the PREVAMIC study","volume":"12","author":"Ruiz-Hueso","year":"2023","journal-title":"J Clin Med"},{"issue":"24","key":"10.1016\/j.jmccpl.2025.100489_bb0025","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy diagnosis of cardiac transthyretin amyloidosis","volume":"133","author":"Gillmore","year":"2016","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.jmccpl.2025.100489_bb0030","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2022.11.022","article-title":"2023 ACC expert consensus decision pathway on comprehensive multidisciplinary care for the patient with cardiac amyloidosis: a report of the American College of Cardiology solution set oversight committee","volume":"81","author":"Kittleson","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.jmccpl.2025.100489_bb0035","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1007\/s12350-019-01760-6","article-title":"ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging","volume":"26","author":"Dorbala","year":"2019","journal-title":"J Nucl Cardiol"},{"issue":"6","key":"10.1016\/j.jmccpl.2025.100489_bb0040","article-title":"Nuclear imaging for the diagnosis of cardiac amyloidosis in 2021","volume":"11","author":"Li","year":"2021","journal-title":"Diagnostics (Basel)"},{"issue":"1","key":"10.1016\/j.jmccpl.2025.100489_bb0045","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1186\/s12872-024-04201-6","article-title":"Comparative analysis of MitraClip\/TriClip and PASCAL in transcatheter tricuspid valve repair for tricuspid regurgitation: a systematic review and meta-analysis","volume":"24","author":"Balata","year":"2024","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.jmccpl.2025.100489_bb0050","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"350","author":"Shamseer","year":"2015","journal-title":"BMJ (Clinical research ed)"},{"issue":"8","key":"10.1016\/j.jmccpl.2025.100489_bb0055","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.jmccpl.2025.100489_bb0060","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/s12928-025-01128-3","article-title":"Cerebral embolic protection in transcatheter aortic valve implantation (TAVI): a pooled analysis of 4091 patients","volume":"40","author":"Balata","year":"2025","journal-title":"Cardiovasc Interv Ther"},{"issue":"2","key":"10.1016\/j.jmccpl.2025.100489_bb0065","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.119.010249","article-title":"Efficient 1-hour Technetium-99 m pyrophosphate imaging protocol for the diagnosis of transthyretin cardiac amyloidosis","volume":"13","author":"Masri","year":"2020","journal-title":"Circ Cardiovasc Imaging"},{"issue":"11","key":"10.1016\/j.jmccpl.2025.100489_bb0070","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.hlc.2016.12.017","article-title":"The utility of (99m)Tc-DPD scintigraphy in the diagnosis of cardiac amyloidosis: an Australian experience","volume":"26","author":"Moore","year":"2017","journal-title":"Heart Lung Circ"},{"issue":"6","key":"10.1016\/j.jmccpl.2025.100489_bb0075","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.jcmg.2020.08.027","article-title":"Diagnosing transthyretin cardiac amyloidosis by technetium Tc 99m pyrophosphate: a test in evolution","volume":"14","author":"Poterucha","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"issue":"5","key":"10.1016\/j.jmccpl.2025.100489_bb0080","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1007\/s12350-020-02139-8","article-title":"Technetium pyrophosphate nuclear scintigraphy for cardiac amyloidosis: imaging at 1 vs 3 hours and planar vs SPECT\/CT","volume":"27","author":"Sperry","year":"2020","journal-title":"J Nucl Cardiol"},{"issue":"19","key":"10.1016\/j.jmccpl.2025.100489_bb0085","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1093\/eurheartj\/ehs397","article-title":"Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases","volume":"34","author":"Rapezzi","year":"2013","journal-title":"Eur Heart J"},{"issue":"Suppl. 1","key":"10.1016\/j.jmccpl.2025.100489_bb0090","first-page":"42","article-title":"Imaging of cardiac amyloidosis by (99m)Tc-PYP scintigraphy","volume":"18","author":"Papantoniou","year":"2015","journal-title":"Hell J Nucl Med"},{"issue":"4","key":"10.1016\/j.jmccpl.2025.100489_bb0095","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s11604-022-01364-0","article-title":"New quantitative indices of cardiac amyloidosis with (99m)Tc-pyrophosphate scintigraphy","volume":"41","author":"Matsuda","year":"2023","journal-title":"Jpn J Radiol"},{"issue":"1","key":"10.1016\/j.jmccpl.2025.100489_bb0100","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s12350-022-02960-3","article-title":"Quantitative (99m)Tc-DPD-SPECT\/CT assessment of cardiac amyloidosis","volume":"30","author":"Kessler","year":"2023","journal-title":"J Nucl Cardiol"},{"issue":"2","key":"10.1016\/j.jmccpl.2025.100489_bb0105","first-page":"101","article-title":"Diagnostic score for the detection of cardiac amyloidosis in patients with left ventricular hypertrophy and impact on prognosis","volume":"24","author":"Cariou","year":"2017","journal-title":"Int. J. Experiment. Clin. Invest"},{"issue":"8","key":"10.1016\/j.jmccpl.2025.100489_bb0110","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1001\/jamacardio.2016.2839","article-title":"Multicenter study of planar technetium 99m pyrophosphate cardiac imaging: predicting survival for patients with ATTR cardiac amyloidosis","volume":"1","author":"Castano","year":"2016","journal-title":"JAMA Cardiol"},{"issue":"5","key":"10.1016\/j.jmccpl.2025.100489_bb0115","first-page":"440","article-title":"Role of cardiac scintigraphy with 99mTc-DPD in the differentiation of cardiac amyloidosis subtype","volume":"65","author":"Haro-del Moral","year":"2012","journal-title":"Rev Esp Cardiol"},{"issue":"1","key":"10.1016\/j.jmccpl.2025.100489_bb0120","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s12350-019-01643-w","article-title":"Semi-quantitative indices of cardiac uptake in patients with suspected cardiac amyloidosis undergoing 99mTc-HMDP scintigraphy","volume":"28","author":"Gallini","year":"2021","journal-title":"J Nucl Cardiol"},{"issue":"2","key":"10.1016\/j.jmccpl.2025.100489_bb0125","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s12350-019-01831-8","article-title":"(99m)technetium pyrophosphate scintigraphy with cadmium zinc telluride cameras is a highly sensitive and specific imaging modality to diagnose transthyretin cardiac amyloidosis","volume":"27","author":"Flaherty","year":"2020","journal-title":"J Nucl Cardiol"},{"issue":"2","key":"10.1016\/j.jmccpl.2025.100489_bb0130","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s12350-017-0922-z","article-title":"Accuracy of 99mTc-hydroxymethylene diphosphonate scintigraphy for diagnosis of transthyretin cardiac amyloidosis","volume":"26","author":"Cappelli","year":"2019","journal-title":"J Nucl Cardiol"},{"issue":"2","key":"10.1016\/j.jmccpl.2025.100489_bb0135","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/CIRCIMAGING.112.000132","article-title":"(99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses","volume":"6","author":"Bokhari","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"issue":"2","key":"10.1016\/j.jmccpl.2025.100489_bb0140","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jcmg.2013.08.015","article-title":"CMR-based differentiation of AL and ATTR cardiac amyloidosis","volume":"7","author":"Dungu","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"issue":"9","key":"10.1016\/j.jmccpl.2025.100489_bb0145","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/RLI.0b013e318059e021","article-title":"MR-relaxometry of myocardial tissue: significant elevation of T1 and T2 relaxation times in cardiac amyloidosis","volume":"42","author":"Hosch","year":"2007","journal-title":"Investig Radiol"},{"issue":"4","key":"10.1016\/j.jmccpl.2025.100489_bb0150","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.jcmg.2012.11.013","article-title":"Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis","volume":"6","author":"Karamitsos","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"issue":"2","key":"10.1016\/j.jmccpl.2025.100489_bb0155","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3109\/13506129.2015.1020153","article-title":"Comparison of different types of cardiac amyloidosis by cardiac magnetic resonance imaging","volume":"22","author":"Kristen","year":"2015","journal-title":"Amyloid: International Journal of Experimental & Clinical Investigation"},{"issue":"2","key":"10.1016\/j.jmccpl.2025.100489_bb0160","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1161\/01.CIR.0000152819.97857.9D","article-title":"Cardiovascular magnetic resonance in cardiac amyloidosis","volume":"111","author":"Maceira","year":"2005","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.jmccpl.2025.100489_bb0165","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jacc.2017.05.053","article-title":"Magnetic resonance in transthyretin cardiac amyloidosis","volume":"70","author":"Martinez-Naharro","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.jmccpl.2025.100489_bb0170","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.jcmg.2012.04.006","article-title":"Quantification of extracellular matrix expansion by CMR in infiltrative heart disease","volume":"5","author":"Mongeon","year":"2012","journal-title":"J Am Coll Cardiol Img"},{"issue":"2","key":"10.1016\/j.jmccpl.2025.100489_bb0175","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jcmg.2009.09.023","article-title":"Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis","volume":"3","author":"Syed","year":"2010","journal-title":"JACC Cardiovasc Imaging"},{"issue":"2","key":"10.1016\/j.jmccpl.2025.100489_bb0180","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jcmg.2015.05.014","article-title":"Causes and consequences of longitudinal LV dysfunction assessed by 2D strain echocardiography in cardiac amyloidosis","volume":"9","author":"Ternacle","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"issue":"10","key":"10.1016\/j.jmccpl.2025.100489_bb0185","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jacc.2007.10.049","article-title":"Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy","volume":"51","author":"Vogelsberg","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.jmccpl.2025.100489_bb0190","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jcmg.2013.09.019","article-title":"CMR imaging with rapid visual T1 assessment predicts mortality in patients suspected of cardiac amyloidosis","volume":"7","author":"White","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"issue":"4","key":"10.1016\/j.jmccpl.2025.100489_bb0195","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.amjcard.2008.09.105","article-title":"Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in light-chain cardiac amyloidosis","volume":"103","author":"Ruberg","year":"2009","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1016\/j.jmccpl.2025.100489_bb0200","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.amjcard.2015.05.021","article-title":"Characterization of cardiac amyloidosis by atrial late gadolinium enhancement using contrast-enhanced cardiac magnetic resonance imaging and correlation with left atrial conduit and contractile function","volume":"116","author":"Kwong","year":"2015","journal-title":"Am J Cardiol"},{"issue":"16","key":"10.1016\/j.jmccpl.2025.100489_bb0205","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1161\/CIRCULATIONAHA.115.016567","article-title":"Prognostic value of late Gadolinium enhancement cardiovascular magnetic resonance in cardiac amyloidosis","volume":"132","author":"Fontana","year":"2015","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.jmccpl.2025.100489_bb0210","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1093\/ehjci\/jew101","article-title":"Clinical and prognostic utility of cardiovascular magnetic resonance imaging in myeloma patients with suspected cardiac amyloidosis","volume":"17","author":"Bhatti","year":"2016","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"23","key":"10.1016\/j.jmccpl.2025.100489_bb0215","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1093\/eurheartj\/ehv583","article-title":"Prevalence and clinical phenotype of hereditary transthyretin amyloid cardiomyopathy in patients with increased left ventricular wall thickness","volume":"37","author":"Damy","year":"2016","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.jmccpl.2025.100489_bb0220","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1253\/circj.CJ-16-0364","article-title":"Left atrial morphology, size and function in patients with transthyretin cardiac amyloidosis and primary hypertrophic cardiomyopathy - comparative strain imaging study","volume":"80","author":"Gregorio","year":"2016","journal-title":"Circ J"},{"issue":"1","key":"10.1016\/j.jmccpl.2025.100489_bb0225","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s12471-017-1046-4","article-title":"Role of cardiovascular magnetic resonance in suspected cardiac amyloidosis: late gadolinium enhancement pattern as mortality predictor","volume":"26","author":"Baroni","year":"2018","journal-title":"Neth Hear J"},{"issue":"12","key":"10.1016\/j.jmccpl.2025.100489_bb0230","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.jcmg.2009.08.008","article-title":"Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis","volume":"2","author":"Austin","year":"2009","journal-title":"J Am Coll Cardiol Img"},{"issue":"10","key":"10.1016\/j.jmccpl.2025.100489_bb0240","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1007\/s12325-015-0250-0","article-title":"Light chain amyloidosis: patient experience survey from the Amyloidosis Research Consortium","volume":"32","author":"Lousada","year":"2015","journal-title":"Adv Ther"},{"issue":"7","key":"10.1016\/j.jmccpl.2025.100489_bb0245","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1253\/circj.CJ-16-1259","article-title":"Identification and assessment of cardiac amyloidosis by myocardial strain analysis of cardiac magnetic resonance imaging","volume":"81","author":"Oda","year":"2017","journal-title":"Circ J"},{"issue":"1","key":"10.1016\/j.jmccpl.2025.100489_bb0250","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000487367","article-title":"Cardiac magnetic resonance imaging of the myocardium in chronic kidney disease","volume":"43","author":"Kis","year":"2018","journal-title":"Kidney Blood Press Res"},{"issue":"1","key":"10.1016\/j.jmccpl.2025.100489_bb0255","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1161\/CIRCIMAGING.112.978627","article-title":"Quantification of myocardial extracellular volume fraction in systemic AL amyloidosis: an equilibrium contrast cardiovascular magnetic resonance study","volume":"6","author":"Banypersad","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"issue":"2","key":"10.1016\/j.jmccpl.2025.100489_bb0260","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10554-019-01717-3","article-title":"Pooled summary of native T1 value and extracellular volume with MOLLI variant sequences in normal subjects and patients with cardiovascular disease","volume":"36","author":"Vo","year":"2020","journal-title":"Int J Card Imaging"},{"issue":"1","key":"10.1016\/j.jmccpl.2025.100489_bb0265","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12968-017-0389-8","volume":"19","author":"Messroghli","year":"2017","journal-title":"J Cardiovasc Magn Reson"},{"issue":"3","key":"10.1016\/j.jmccpl.2025.100489_bb0270","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11886-018-0961-3","article-title":"Myocardial extracellular volume quantification by cardiovascular magnetic resonance and computed tomography","volume":"20","author":"Scully","year":"2018","journal-title":"Curr Cardiol Rep"},{"issue":"5","key":"10.1016\/j.jmccpl.2025.100489_bb0275","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/jnen\/nlac022","article-title":"Distinct patterns of amyloid pathology in autopsies of transthyretin S77Y and A97S amyloidosis: significance of symptomatology and cell biology","volume":"81","author":"Chang","year":"2022","journal-title":"J Neuropathol Exp Neurol"},{"issue":"6","key":"10.1016\/j.jmccpl.2025.100489_bb0280","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.jcmg.2019.10.015","article-title":"Low sensitivity of bone scintigraphy in detecting Phe64Leu mutation-related transthyretin cardiac amyloidosis","volume":"13","author":"Musumeci","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"issue":"4","key":"10.1016\/j.jmccpl.2025.100489_bb0285","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/acn3.51741","article-title":"Ser77Tyr transthyretin amyloidosis in Israel: Initial manifestations and diagnostic features","volume":"10","author":"Dori","year":"2023","journal-title":"Ann Clin Transl Neurol"},{"issue":"6","key":"10.1016\/j.jmccpl.2025.100489_bb0290","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2005.05.073","article-title":"Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy","volume":"46","author":"Perugini","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.jmccpl.2025.100489_bb0295","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1007\/s12350-019-01893-8","article-title":"Quantitative 99mTc-DPD SPECT\/CT in patients with suspected ATTR cardiac amyloidosis: feasibility and correlation with visual scores","volume":"27","author":"Caobelli","year":"2020","journal-title":"J Nucl Cardiol"},{"issue":"6","key":"10.1016\/j.jmccpl.2025.100489_bb0300","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.jcmg.2020.03.020","article-title":"DPD quantification in cardiac amyloidosis: a novel imaging biomarker","volume":"13","author":"Scully","year":"2020","journal-title":"J Am Coll Cardiol Img"},{"issue":"16","key":"10.1016\/j.jmccpl.2025.100489_bb0305","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/eurheartj\/ehab072","article-title":"Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC working group on myocardial and pericardial diseases","volume":"42","author":"Garcia-Pavia","year":"2021","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1016\/j.jmccpl.2025.100489_bb0310","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1136\/jnnp-2012-302548","article-title":"Amyloid imaging in Alzheimer\u2019s disease: comparison of florbetapir and Pittsburgh compound-B positron emission tomography","volume":"83","author":"Wolk","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/j.jmccpl.2025.100489_bb0315","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4103\/0971-6203.25665","article-title":"Positron emission tomography: an overview","volume":"31","author":"Shukla","year":"2006","journal-title":"J Med Phys"},{"issue":"3","key":"10.1016\/j.jmccpl.2025.100489_bb0320","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s13139-015-0338-0","article-title":"Imaging findings and literature review of (18)F-FDG PET\/CT in primary systemic AL amyloidosis","volume":"49","author":"Lee","year":"2015","journal-title":"Nucl Med Mol Imaging"},{"issue":"1","key":"10.1016\/j.jmccpl.2025.100489_bb0325","doi-asserted-by":"crossref","DOI":"10.1186\/s12872-021-02292-z","article-title":"Diagnostic performance of CMR, SPECT, and PET imaging for the detection of cardiac amyloidosis: a meta-analysis","volume":"21","author":"Wu","year":"2021","journal-title":"BMC Cardiovasc Disord"}],"container-title":["Journal of Molecular and Cellular Cardiology Plus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772976125002089?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772976125002089?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:41:47Z","timestamp":1765327307000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772976125002089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":64,"alternative-id":["S2772976125002089"],"URL":"https:\/\/doi.org\/10.1016\/j.jmccpl.2025.100489","relation":{},"ISSN":["2772-9761"],"issn-type":[{"type":"print","value":"2772-9761"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiac magnetic resonance imaging and cardiac scintigraphy in the diagnosis of cardiac amyloidosis: A meta-analysis of 4866 patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology Plus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmccpl.2025.100489","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100489"}}